MedTrace Logo

Hyperbaric Oxygen for Carbon Monoxide Induced Chronic Encephalopathy

NCT04118491 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2024-09-03

No results posted yet for this study

Summary

In some patients, a few days or weeks after recovery from carbon monoxide poisoning, new symptoms develop. These can affect mood, ability to think or remember clearly, and movements. Some people develop movement problems that are similar to Parkinson's disease. This damage to brain tissue is called "encephalopathy," and this study will look at the effect of pressurized oxygen therapy on long term, or chronic, encephalopathy.

Conditions

  • Carbon Monoxide Poisoning
  • Chronic Encephalopathy

Interventions

DEVICE

hyperbaric oxygen and sham hyperbaric oxygen

see arm descriptions

Sponsors & Collaborators

  • University of Nebraska

    lead OTHER

Principal Investigators

  • Jeffrey Cooper, MD · University of Nebraska

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
10 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-06
Primary Completion
2023-06-06
Completion
2023-06-06
FDA Device
Yes

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04118491 on ClinicalTrials.gov